Nipride Rtu
NDC Package 51754-1018-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Nipride Rtu is diseases with compensatory hypertension (e.g., coarctation of the aorta, arteriovenous shunting).Inadequate cerebral circulation or in moribund patients (A.S.A. Marketed by Exela Pharma Sciences, Llc, this product is identified by NDC 51754-1018 and is authorized under FDA application NDA209387.

Identification & Billing

NDC Package Code
51754-1018-1
Package Description
1 VIAL in 1 VIAL / 50 mL in 1 VIAL
Product Code
51754-1018
11-Digit Billing Format
51754101801
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Nipride Rtu
Dosage Form
-
Usage Information
Diseases with compensatory hypertension (e.g., coarctation of the aorta, arteriovenous shunting).Inadequate cerebral circulation or in moribund patients (A.S.A. Class 5E) coming to emergency surgery.Patients with congenital (Leber’s) optic atrophy or with tobacco amblyopia.  Acute heart failure associated with reduced peripheral vascular resistance.Concomitant use with sildenafil, tadalafil, vardenifil, or riociguat. 

Regulatory & Marketing

Labeler Name
Exela Pharma Sciences, Llc
FDA Application #
NDA209387
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-09-2018
End Marketing Date
08-30-2019
Listing Expiration
08-30-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51754-1018-1 identifies a specific commercial package of 1 vial in 1 vial / 50 ml in 1 vial of Nipride Rtu, labeled by Exela Pharma Sciences, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Exela Pharma Sciences, Llc on February 09, 2018. The current certification is valid through August 30, 2019.

How is this Exela Pharma Sciences, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51754101801. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51754-1018-1
11-Digit CMS (5-4-2)
51754-1018-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.